1. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway
   Hui Li et al, 2017, Canadian Journal of Physiology and Pharmacology CrossRef
2. Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells
   Xin Xu et al, 2018, Cancer Science CrossRef
3. Progression of Breast Cancer Cells Was Enhanced by Endocrine-Disrupting Chemicals, Triclosan and Octylphenol, via an Estrogen Receptor-Dependent Signaling Pathway in Cellular and Mouse Xenograft Models
   Hye-Rim Lee et al, 2014, Chemical Research in Toxicology CrossRef
4. Mefloquine binding to human acyl-CoA binding protein leads to redox stress-mediated apoptotic death of human neuroblastoma cells
   Abhishek Kumar et al, 2020, NeuroToxicology CrossRef
5. A novel computational approach for drug repurposing using systems biology
   Azam Peyvandipour et al, 2018, Bioinformatics CrossRef
6. Drug Repurposing for Retinoblastoma: Recent Advances
   Kamakshi Dandu et al, 2019, Current Topics in Medicinal Chemistry CrossRef
7. Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
   Yifei Xie et al, 2020, Frontiers in Oncology CrossRef
8. 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine
   Giselle Barbosa-Lima et al, 2017, European Journal of Medicinal Chemistry CrossRef
9. Influence of mefloquine administration during early pregnancy on rat embryonic development
   Mai Helmy El-Dakdoky, 2015, Toxicology Mechanisms and Methods CrossRef
10. Lysosome Inhibition by Mefloquine Preferentially Enhances the Cytotoxic Effects of Tyrosine Kinase Inhibitors in Blast Phase Chronic Myeloid Leukemia
    Hui Lam Yi et al, 2019, Translational Oncology CrossRef
11. A Comparative Study of Cluster Detection Algorithms in Protein–Protein Interaction for Drug Target Discovery and Drug Repurposing
    Jun Ma et al, 2019, Frontiers in Pharmacology CrossRef
12. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation
    Michio Iwata et al, 2018, Journal of Medicinal Chemistry CrossRef
13. Anti-malarials are anti-cancers and vice versa – One arrow two sparrows
    Chanakya Nath Kundu et al, 2015, Acta Tropica CrossRef
14. New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
    Diana Duarte et al, 2020, Biomolecules CrossRef
15. Inhibitors of ZIKV Replication and Infection
    Suzane Ramos Silva et al, 2018, Zika Virus and Diseases CrossRef
16. Mefloquine as a dual inhibitor of glioblastoma angiogenesis and glioblastoma via disrupting lysosomal function
    Bing Wan et al, 2021, Biochemical and Biophysical Research Communications CrossRef
17. Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway
    Yanwei Liu et al, 2016, Biochemical and Biophysical Research Communications CrossRef
18. Malaria and Cancer: a critical review on the established associations and new perspectives
    Toby Ellis et al, 2021, Infectious Agents and Cancer CrossRef
19. OPTIMIZATION AND CHARACTERIZATION OF ESSENTIAL OILS FORMULATION FOR ENHANCED STABILITY AND DRUG DELIVERY SYSTEM OF MEFLOQUINE
    PRIYADARSHINI MOHAPATRA et al, 2023, International Journal of Applied Pharmaceutics CrossRef
20. Transcriptomics analysis reveals distinct mechanism of breast cancer stem cells regulation in mammospheres from MCF-7 and T47D cells
    Adam Hermawan et al, 2024, Heliyon CrossRef
21. Differential Stabilities of Mefloquine-Bound Human and Plasmodium falciparum Acyl-CoA-Binding Proteins
    Abhishek Kumar et al, 2021, ACS Omega CrossRef